Under the terms of this relationship, HnG Medical will represent and negotiate medical coating services and royalty/fee based license agreements in China.
In addition to the urinary catheter and central venous catheter and cardiovascular stent businesses, HnG Medical will focus on the application of Hydromer’s proprietary Hydromer hydrophilic coatings on various Pebax, polyamide and polyurethane cardiovascular, neurovascular and similar microcatheters catheters.
Martin Dyck, executive vice president of Hydromer, said: “I am delighted with our new relationship which will provide Hydromer with access to one of the fastest growing economies in the world. What is of significant importance is that HnG Medical will aid Hydromer in the preparation of medical coating agreements to be enforceable under Chinese law and providing protection for Hydromer’s intellectual property.”